Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C015929 |
8-((4-chlorophenyl)thio)cyclic-3',5'-AMP |
[1-Methyl-3-isobutylxanthine co-treated with 8-((4-chlorophenyl)thio)cyclic-3',5'-AMP] results in increased activity of [SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein] | affects binding|affects cotreatment|increases activity | 15161604
|
C055656 |
8-((4-chlorophenyl)thio)cyclic-3',5'-GMP |
8-((4-chlorophenyl)thio)cyclic-3',5'-GMP results in increased activity of [SCNN1A binds to SCNN1B binds to SCNN1G binds to SCNN1D] | affects binding|increases activity | 19359370
|
C090860 |
8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate |
8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate results in increased activity of [SCNN1A binds to SCNN1B binds to SCNN1G binds to SCNN1D] | affects binding|increases activity | 19359370
|
C063261 |
acetylleucyl-leucyl-norleucinal |
acetylleucyl-leucyl-norleucinal results in decreased expression of SCNN1G mRNA | decreases expression | 15564131
|
C063261 |
acetylleucyl-leucyl-norleucinal |
acetylleucyl-leucyl-norleucinal results in increased methylation of SCNN1G promoter | increases methylation | 15564131
|
D000450 |
Aldosterone |
Aldosterone results in increased expression of SCNN1G mRNA | increases expression | 18665318
|
D000450 |
Aldosterone |
Aldosterone results in increased expression of SCNN1G protein | increases expression | 18665318
|
D000584 |
Amiloride |
Amiloride inhibits the reaction [[SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein] which results in increased transport of Sodium] | affects binding|decreases reaction|increases transport | 18665318
|
D000584 |
Amiloride |
Amiloride results in decreased activity of [SCNN1A binds to SCNN1B binds to SCNN1G binds to SCNN1D] | affects binding|decreases activity | 19359370
|
D000584 |
Amiloride |
Amiloride results in decreased activity of [SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein] | affects binding|decreases activity | 18665318 18398334
|
D000584 |
Amiloride |
Amiloride affects the activity of SCNN1G protein | affects activity | 8617496
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of SCNN1G mRNA | affects expression | 16483693
|
C013407 |
benzamil |
benzamil results in decreased activity of [SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein] | affects binding|decreases activity | 18024548
|
D020126 |
Brefeldin A |
Brefeldin A inhibits the reaction [Terbutaline inhibits the reaction [Oxygen deficiency results in decreased expression of SCNN1G protein]] | decreases expression|decreases reaction | 12608646
|
D001965 |
Bromides |
Bromides results in decreased activity of [SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein] | affects binding|decreases activity | 16027156
|
C055494 |
caffeic acid phenethyl ester |
caffeic acid phenethyl ester inhibits the reaction [Diethylnitrosamine results in increased expression of SCNN1G mRNA] | decreases reaction|increases expression | 20360939
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of SCNN1G protein | affects expression | 16192424
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in decreased expression of SCNN1G mRNA | decreases expression | 16644059
|
D002712 |
Chlorides |
Chlorides results in decreased activity of [SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein] | affects binding|decreases activity | 15161604 16027156
|
D003894 |
Deamino Arginine Vasopressin |
Deamino Arginine Vasopressin results in increased expression of SCNN1G mRNA | increases expression | 11711512
|
D003907 |
Dexamethasone |
Dexamethasone results in increased expression of SCNN1G mRNA | increases expression | 12682491
|
D004052 |
Diethylnitrosamine |
caffeic acid phenethyl ester inhibits the reaction [Diethylnitrosamine results in increased expression of SCNN1G mRNA] | decreases reaction|increases expression | 20360939
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of SCNN1G mRNA | increases expression | 20360939
|
D004280 |
Dobutamine |
Dobutamine results in increased expression of SCNN1G mRNA | increases expression | 16638327
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of SCNN1G mRNA | decreases expression | 15564131
|
D004317 |
Doxorubicin |
Doxorubicin results in increased methylation of SCNN1G promoter | increases methylation | 15564131
|
D004967 |
Estrogens |
Estrogens affects the activity of [SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein] | affects activity|affects binding | 17939260
|
D004967 |
Estrogens |
Estrogens affects the expression of SCNN1G mRNA | affects expression | 17939260
|
D004967 |
Estrogens |
Estrogens affects the expression of SCNN1G protein | affects expression | 17939260
|
D005839 |
Gentamicins |
Gentamicins results in increased expression of SCNN1G protein | increases expression | 16850027
|
D006854 |
Hydrocortisone |
Hydrocortisone results in increased expression of SCNN1G mRNA | increases expression | 17715387
|
D007454 |
Iodides |
Iodides results in decreased activity of [SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein] | affects binding|decreases activity | 16027156
|
D015056 |
1-Methyl-3-isobutylxanthine |
[1-Methyl-3-isobutylxanthine co-treated with 8-((4-chlorophenyl)thio)cyclic-3',5'-AMP] results in increased activity of [SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein] | affects binding|affects cotreatment|increases activity | 15161604
|
D008094 |
Lithium |
[SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein] which results in increased transport of Lithium | affects binding|increases transport | 18665318
|
D009566 |
Nitrates |
Nitrates results in decreased activity of [SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein] | affects binding|decreases activity | 16027156
|
D010100 |
Oxygen |
Brefeldin A inhibits the reaction [Terbutaline inhibits the reaction [Oxygen deficiency results in decreased expression of SCNN1G protein]] | decreases expression|decreases reaction | 12608646
|
D010100 |
Oxygen |
Oxygen deficiency results in decreased expression of SCNN1G protein | decreases expression | 12372821
|
D010100 |
Oxygen |
Terbutaline inhibits the reaction [Oxygen deficiency results in decreased expression of SCNN1G protein] | decreases expression|decreases reaction | 12372821
|
D010126 |
Ozone |
Ozone results in decreased expression of SCNN1G mRNA | decreases expression | 16716893
|
C060836 |
pioglitazone |
pioglitazone promotes the reaction [PPARG protein binds to SCNN1G intron] | affects binding|increases reaction | 16007095
|
C060836 |
pioglitazone |
pioglitazone results in increased expression of SCNN1G mRNA | increases expression | 16007095
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of SCNN1G mRNA | increases expression | 18301758
|
D011188 |
Potassium |
[SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein] which results in increased transport of Potassium | affects binding|increases transport | 18665318
|
D011374 |
Progesterone |
Progesterone affects the activity of [SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein] | affects activity|affects binding | 17939260
|
D011374 |
Progesterone |
Progesterone affects the expression of SCNN1G mRNA | affects expression | 17939260
|
D011374 |
Progesterone |
Progesterone affects the expression of SCNN1G protein | affects expression | 17939260
|
D011374 |
Progesterone |
Progesterone results in decreased activity of [SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein] | affects binding|decreases activity | 16172119
|
D011692 |
Puromycin Aminonucleoside |
Puromycin Aminonucleoside results in decreased expression of SCNN1G mRNA | decreases expression | 16020936
|
D012964 |
Sodium |
Amiloride inhibits the reaction [[SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein] which results in increased transport of Sodium] | affects binding|decreases reaction|increases transport | 18665318
|
D012964 |
Sodium |
[SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein binds to SCNN1D protein] which results in increased transport of Sodium | affects binding|increases transport | 19359370
|
D012964 |
Sodium |
[SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein] which affects the transport of Sodium | affects binding|affects transport | 18398334
|
D012964 |
Sodium |
[SCNN1A protein binds to SCNN1B protein binds to SCNN1G protein] which results in increased transport of Sodium | affects binding|increases transport | 18665318
|
D012964 |
Sodium |
[SCNN1A protein binds to SCNN1B protein mutant form binds to SCNN1G protein] which results in increased transport of Sodium | affects binding|increases transport | 18398334
|
D012964 |
Sodium |
SCNN1G protein affects the transport of Sodium | affects transport | 8617496
|
D012964 |
Sodium |
Sodium affects the expression of SCNN1G mRNA | affects expression | 15261163
|
D017673 |
Sodium Chloride, Dietary |
Sodium Chloride, Dietary results in decreased expression of SCNN1G protein | decreases expression | 18024548
|
D013726 |
Terbutaline |
Brefeldin A inhibits the reaction [Terbutaline inhibits the reaction [Oxygen deficiency results in decreased expression of SCNN1G protein]] | decreases expression|decreases reaction | 12608646
|
D013726 |
Terbutaline |
Terbutaline inhibits the reaction [Oxygen deficiency results in decreased expression of SCNN1G protein] | decreases expression|decreases reaction | 12372821
|
D013890 |
Thiourea |
Thiourea results in decreased expression of SCNN1G mRNA | decreases expression | 15248066
|
C024746 |
tobacco tar |
tobacco tar results in decreased expression of SCNN1G mRNA | decreases expression | 19559774
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Terbutaline |
4.54 | 14610225 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.18 | 18287403 |
MESH:D058186 |
Acute Kidney Injury |
|
Gentamicins |
4.21 | 11274264 |
MESH:D055371 |
Acute Lung Injury |
|
Oxygen |
8.06 | 16759491 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
8.06 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
2.47 | 17418594 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
2.63 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
8.83 | 19061943 16434500 17620307 19052882 18056438 17162532 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
8.83 | 16434500 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.18 | 21441931 |
MESH:D000544 |
Alzheimer Disease |
|
Lithium |
4.39 | 19621015 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
4.39 | 15513908 |
MESH:D000686 |
Amyloidosis |
|
Terbutaline |
5.26 | 7986221 |
MESH:D000860 |
Anoxia |
|
Oxygen |
4.67 | 20872349 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
3.30 | 17659584 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.46 | 15570426 |
MESH:D001249 |
Asthma |
|
Ozone |
2.52 | 16373670 17854713 |
MESH:D050197 |
Atherosclerosis |
|
Oxygen |
3.58 | 16391483 |
MESH:D001321 |
Autistic Disorder |
|
pioglitazone |
3.13 | 17207275 |
MESH:D001321 |
Autistic Disorder |
|
Terbutaline |
3.13 | 16417856 17400887 |
MESH:D001714 |
Bipolar Disorder |
|
Lithium |
4.12 | 17594078 20338123 19153942 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
2.81 | 19483382 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.31 | 14601052 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
4.95 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
3.89 | 15845082 15665606 15380490 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.48 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
1.98 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
1.98 | 15994142 16096432 15939500 19526202 15634643 16322301 15692762 16115903 16826403 15668708 18628466 18382427 15993339 16935488 16264153 15567936 16595493 17983394 15136595 18234424 18695136 11325840 17369602 17426702 |
MESH:D001943 |
Breast Neoplasms |
|
Oxygen |
1.98 | 17263869 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
1.98 | 16175315 15562024 17614352 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.38 | 18417511 15516495 16777450 14754758 17626835 18315731 19059883 |
OMIM:613071 |
BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3 |
marker/mechanism |
|
| |
MESH:D002100 |
Cachexia |
|
Ozone |
4.36 | 16183385 |
MESH:D019559 |
Capillary Leak Syndrome |
|
Terbutaline |
5.47 | 9428835 11713377 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.41 | 10355542 16227642 16097048 16192424 16124888 15700767 18705752 16050911 16011737 15673190 3786805 15721981 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.42 | 16051944 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
6.08 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
6.08 | 20514400 19701751 16935385 20524982 21159647 17978847 17428255 16807293 18665156 17138121 16698587 16502159 18056438 17173139 10672840 19052882 20432363 16328049 16540662 16569478 16779866 18210153 18691550 18506893 16878318 3084413 19107877 19394651 20101231 18393292 18494052 11831363 16830150 16288022 19919837 17761372 10737359 20084675 17162532 19519916 20935162 18785209 18788625 19539802 16681979 19171122 19822196 20727157 19335982 19208518 3581430 20512989 17055752 19418558 18971187 20214788 19383236 20007298 18978308 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
6.08 | 18059187 17876044 16023760 16234567 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estrogens |
6.08 | 15341023 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
2.98 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
2.52 | 6189445 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Amiloride |
4.75 | 14644129 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.28 | 17329180 17351982 17308081 17382496 16952015 16109756 15476868 17131338 16242529 16731534 15811867 15792986 17007740 16364871 16612575 17519947 16455267 16651473 17928571 17974986 16278810 17924179 16269455 15505089 18627295 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.81 | 16243910 17334414 |
MESH:D002318 |
Cardiovascular Diseases |
|
Aldosterone |
4.46 | 11230374 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
6.26 | 7505956 2727394 17174075 21159647 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
tobacco tar |
6.26 | 19559774 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
3.37 | 19052882 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.55 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Hydrocortisone |
3.99 | 15826874 |
MESH:D003092 |
Colitis |
|
Amiloride |
4.74 | 12065299 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
2.43 | 15824018 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18259882 18802399 |
MESH:D003371 |
Cough |
|
Terbutaline |
5.18 | 19679606 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
3.24 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Hydrocortisone |
3.24 | 17728286 |
MESH:D016638 |
Critical Illness |
|
Estrogens |
5.56 | 16670151 |
MESH:D003550 |
Cystic Fibrosis |
marker/mechanism |
|
| 16463024 |
MESH:D003550 |
Cystic Fibrosis |
|
pioglitazone |
4.60 | 19747007 |
MESH:D007644 |
Darier Disease |
|
Lithium |
5.53 | 20338123 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
3.05 | 12438553 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.24 | 18249437 |
MESH:D018500 |
Diabetes Insipidus, Nephrogenic |
|
Lithium |
5.37 | 19244398 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.64 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
pioglitazone |
4.64 | 16023994 12642470 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.12 | 17187935 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
7.42 | 7237001 |
MESH:D003967 |
Diarrhea |
|
Hydrocortisone |
7.42 | 7237001 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
5.59 | 10092053 6623471 15027814 15998439 7120509 19336974 6884620 17522070 7179309 16177239 3732212 7440962 2869522 4309450 21278145 15968718 3786805 19085960 9327722 11566570 10915739 16227642 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
5.59 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
5.59 | 17416283 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
7.79 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Gentamicins |
7.79 | 11033412 15033597 |
MESH:D004417 |
Dyspnea |
|
Oxygen |
4.45 | 20016425 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
4.10 | 12438553 |
MESH:D004487 |
Edema |
|
Dexamethasone |
5.81 | 19703484 |
MESH:D004487 |
Edema |
|
pirinixic acid |
5.81 | 12083418 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.42 | 17692515 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.20 | 17359293 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
3.44 | 16134523 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.77 | 18037988 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.73 | 16302075 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
11.13 | 16045604 12631006 12795759 16239168 19224547 17595544 61145 15959796 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
11.13 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
11.13 | 19236843 20131406 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.21 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
8.13 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Terbutaline |
8.13 | 15467267 |
MESH:D005739 |
Gas Poisoning |
|
Oxygen |
4.83 | 20016425 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.10 | 17150277 |
MESH:D005923 |
Glomerulosclerosis, Focal Segmental |
|
pioglitazone |
4.94 | 16687628 |
MESH:D006130 |
Growth Disorders |
|
Amiloride |
4.51 | 19703807 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.27 | 15692506 |
MESH:D034381 |
Hearing Loss |
|
Gentamicins |
4.56 | 18024279 15968427 17868369 19130971 |
MESH:D006330 |
Heart Defects, Congenital |
|
Lithium |
4.01 | 19638421 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.22 | 16244371 14766674 16707910 16244372 18674790 16495754 16330681 18006777 12587719 17875725 16144979 16879835 17888722 |
MESH:D006333 |
Heart Failure |
|
Dobutamine |
10.61 | 17440445 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
10.61 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
10.61 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.56 | 15692506 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.24 | 19110552 19900420 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
2.63 | 19176532 16221962 19772884 18467677 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
2.93 | 7520565 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.10 | 15147373 18501091 17606976 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.15 | 16899240 |
MESH:D053565 |
Hypercalciuria |
|
Gentamicins |
5.32 | 17652376 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.85 | 20558911 |
MESH:D006973 |
Hypertension |
marker/mechanism |
|
| 15198480 |
MESH:D006973 |
Hypertension |
|
Amiloride |
8.29 | 19344079 18524855 15174897 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
8.29 | 17042910 |
MESH:D006973 |
Hypertension |
|
Sodium Chloride, Dietary |
8.29 | 18524855 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.72 | 15338365 |
MESH:D006985 |
Hyperventilation |
|
Terbutaline |
5.70 | 10895896 |
MESH:D007008 |
Hypokalemia |
|
Terbutaline |
5.71 | 17292646 |
MESH:D020514 |
Hypokalemic Periodic Paralysis |
|
Amiloride |
11.85 | 19822448 |
MESH:D020514 |
Hypokalemic Periodic Paralysis |
|
Potassium |
11.85 | 19822448 |
MESH:D007022 |
Hypotension |
marker/mechanism |
|
| 11463765 |
MESH:D007077 |
Ileal Diseases |
|
1-Methyl-3-isobutylxanthine |
5.05 | 18306037 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.03 | 15869954 |
MESH:D007249 |
Inflammation |
|
Amiloride |
13.74 | 17237260 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
13.74 | 11099482 8960868 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
13.74 | 18785209 |
MESH:D007249 |
Inflammation |
|
pioglitazone |
13.74 | 16908763 |
MESH:D007249 |
Inflammation |
|
Progesterone |
13.74 | 15869954 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.38 | 16306350 |
MESH:D007414 |
Intestinal Neoplasms |
|
caffeic acid phenethyl ester |
4.26 | 10783313 |
MESH:D007579 |
Jejunal Diseases |
|
1-Methyl-3-isobutylxanthine |
5.05 | 18306037 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Gentamicins |
5.34 | 18842672 |
MESH:D007674 |
Kidney Diseases |
|
caffeic acid phenethyl ester |
9.12 | 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
9.12 | 16775033 15699352 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Gentamicins |
9.12 | 19349640 18289764 17934191 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
3.81 | 16707910 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Gentamicins |
4.99 | 11231351 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Gentamicins |
4.16 | 10219319 |
MESH:D053609 |
Lethargy |
|
Terbutaline |
5.93 | 10895896 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.77 | 16085563 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
caffeic acid phenethyl ester |
3.74 | 16766008 |
MESH:D056929 |
Liddle Syndrome |
marker/mechanism |
|
| |
MESH:D056929 |
Liddle Syndrome |
|
Amiloride |
5.60 | 19344079 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
5.89 | 16239168 11408273 17157831 17174718 11903743 17334410 16221502 21278145 16943688 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
5.89 | 19638242 18522880 18665156 20032147 18407596 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
8.04 | 15876570 15925388 15730626 14748882 12445421 15052691 18156304 17708605 15996030 15650968 12958196 15959796 18429990 18472332 16033810 12389079 18210741 15818738 15338365 14716496 14724832 18472094 13678700 16116963 17525996 18317297 17640975 18277467 18205269 17823541 15673190 17481882 18251166 12666154 16027843 12445418 18279442 18054572 12586293 17976157 12741479 17565644 18166357 15370692 20821823 15931870 18395914 16015684 18481824 16011737 11481614 17869086 17900296 17698563 17766677 14512876 18418968 18006644 15057751 14620537 18705752 16136751 12667390 16638106 10355542 17922224 16248980 17761835 17714472 12649538 15123356 18263696 17944888 15362042 18395095 18187930 18339082 12609069 14716833 12546737 18412020 18376398 18420326 12632514 17631135 12632512 16192424 12898905 17721639 17557913 15893842 17805973 16097048 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
8.04 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
8.04 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pioglitazone |
8.04 | 15052691 16484506 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
8.04 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Puromycin Aminonucleoside |
8.04 | 16570917 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
3.71 | 17285989 16246199 15720792 16964402 15830285 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
3.71 | 17034775 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.79 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.36 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
6.51 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
6.51 | 18978307 18648771 19850985 19690152 20118626 10737359 2422723 20101389 20583210 18754104 21047994 20137499 19073162 20405173 20434301 20492335 19551842 19254457 19256749 12771043 19427195 19426721 21071580 12112319 19294768 18644402 21167192 19812893 19255062 19638242 19642983 19499222 20501860 15175105 15885732 20452335 9163691 21278145 16942905 19833225 19996281 18977376 19090486 2862719 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
6.51 | 20007298 15890375 16377806 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
8.52 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
8.52 | 18775883 16842330 18253720 21159647 18164116 18282651 17942915 19126423 18544905 18093689 18079962 3124819 16267830 19519916 19539802 18308698 2563599 19009564 17174075 19004024 9362446 17854601 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
8.52 | 17085340 16842330 |
MESH:D008133 |
Long QT Syndrome |
|
Dobutamine |
4.45 | 19353679 |
MESH:D008171 |
Lung Diseases |
|
Dobutamine |
7.16 | 16638327 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
7.16 | 19066396 8266340 |
MESH:D055370 |
Lung Injury |
|
Oxygen |
8.19 | 18339021 |
MESH:D055370 |
Lung Injury |
|
Ozone |
8.19 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
4.49 | 11195469 15824018 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
4.49 | 21163286 20970405 6695378 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
4.49 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
4.49 | 8597069 7614698 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.19 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.48 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.19 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
5.42 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
5.42 | 17203775 11408345 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.23 | 16827129 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
2.90 | 17638057 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.72 | 10496685 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.16 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.41 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
3.24 | 15867202 16118317 15744524 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.14 | 16239165 |
MESH:D009137 |
Muscular Dystrophy, Animal |
|
Gentamicins |
5.89 | 18694830 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
3.32 | 9809623 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
8.65 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
Lithium |
8.65 | 16288908 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
8.65 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Dobutamine |
4.73 | 12447174 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.66 | 16411023 |
MESH:D009361 |
Neoplasm Invasiveness |
|
Amiloride |
4.94 | 14644129 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
5.34 | 9029167 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
5.34 | 18259882 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
1.77 | 17405874 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
11.66 | 16899518 16636307 |
MESH:D009401 |
Nephrosis |
|
Puromycin Aminonucleoside |
11.66 | 15829708 11170791 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
9.13 | 15640375 16889571 |
MESH:D009404 |
Nephrotic Syndrome |
|
Puromycin Aminonucleoside |
9.13 | 16020936 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.06 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.03 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.73 | 20387270 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.72 | 20558911 |
MESH:D007752 |
Obstetric Labor, Premature |
|
Terbutaline |
5.72 | 14998686 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.81 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
2.40 | 16525653 17393432 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.28 | 16540662 |
MESH:D010538 |
Peritonitis |
|
Ozone |
3.76 | 16369182 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.77 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.77 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Ozone |
4.01 | 18381685 18007984 18929643 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.23 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
3.33 | 21297632 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.68 | 18437689 15897917 16868541 16888761 16729912 15749863 |
MESH:D011507 |
Proteinuria |
|
Gentamicins |
8.94 | 15033597 |
MESH:D011507 |
Proteinuria |
|
pioglitazone |
8.94 | 16687628 |
MESH:D011546 |
Pseudohypoaldosteronism |
marker/mechanism |
|
| 8640238 |
MESH:D011654 |
Pulmonary Edema |
|
Terbutaline |
10.47 | 10903255 |
MESH:D011654 |
Pulmonary Edema |
|
Thiourea |
10.47 | 10849556 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
9.36 | 17922066 |
MESH:D051437 |
Renal Insufficiency |
|
Gentamicins |
9.36 | 17132701 15728788 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.20 | 19058328 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
13.45 | 18379247 11700416 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Oxygen |
13.45 | 18339021 17627322 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Terbutaline |
13.45 | 2878809 |
MESH:D012173 |
Retinitis |
|
Gentamicins |
5.89 | 18644591 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.72 | 18045962 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.66 | 17203757 15675481 15625365 16767912 18313854 17710206 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
3.88 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.41 | 17846226 |
MESH:D012640 |
Seizures |
|
Lithium |
3.74 | 19660546 |
MESH:D012772 |
Shock, Septic |
|
Terbutaline |
5.11 | 3431524 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
2.77 | 15692506 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.19 | 15625365 16767912 17203757 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
3.90 | 15862959 16503802 |
MESH:D013226 |
Status Epilepticus |
|
Lithium |
5.40 | 19570321 19430551 19951488 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
3.94 | 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
1.75 | 18456281 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
3.16 | 15138204 |
MESH:D013398 |
Sudden Infant Death |
|
Oxygen |
5.16 | 12563064 |
MESH:D013610 |
Tachycardia |
|
Terbutaline |
5.14 | 10895896 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
6.34 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
6.34 | 16010429 17909728 |
MESH:D016171 |
Torsades de Pointes |
|
Dobutamine |
4.97 | 19353679 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
2.61 | 17653716 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
4.43 | 1336536 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
3.85 | 17334414 17638931 16364871 17678736 |
MESH:D015837 |
Vestibular Diseases |
|
Gentamicins |
5.16 | 18776599 |
MESH:D014947 |
Wounds and Injuries |
|
Estrogens |
4.43 | 11172683 |